Prolonged renal allograft survival by donor interleukin-6 deficiency: Association with decreased alloantibodies and increased intragraft T regulatory cells

American Journal of Physiology - Renal Physiology

Volumn 302, Issue 2, 2012, Pages

  Wang, Hao ^a   Guan, Qiunong ^b,c   Lan, Zhu ^a   Li, Shuyuan ^b,c   Ge, Wei ^a   Chen, Huifang ^d   Nguan, Christopher Y C ^b,c   Du, Caigan ^b,c  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c VANCOUVER COASTAL HEALTH RESEARCH INSTITUTE   (Canada)

^d UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Alloantibody; Cellular rejection; Humoral rejection; Kidney transplant; Treg cell

Indexed keywords

ALLOANTIBODY; INTERLEUKIN 6; NITROGEN; TRANSCRIPTION FACTOR FOXP3; UREA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL EXPANSION; CELL ISOLATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DELAYED GRAFT FUNCTION; FLUORESCENCE ACTIVATED CELL SORTING; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; IMMUNOHISTOCHEMISTRY; KIDNEY ALLOGRAFT; KIDNEY ALLOGRAFT REJECTION; KIDNEY DONOR; KIDNEY TRANSPLANTATION; KIDNEY TUBULE EPITHELIUM; KNOCKOUT GENE; KNOCKOUT MOUSE; LYMPHOCYTE PROLIFERATION; LYMPHOCYTIC INFILTRATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MOUSE; NEPHROTOMY; NONHUMAN; ORTHOTOPIC TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; UPREGULATION; UREA NITROGEN BLOOD LEVEL; WILD TYPE;

EID: 84855320825     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00258.2011     Document Type: Article

References (36)

1. Afzali B, Mitchell P, Lechler RI, John S, Lombardi G. Translational mini-review series on Th17 cells: induction of interleukin-17 production by regulatory T cells. Clin Exp Immunol 159: 120-130, 2010.
2. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, Weiner HL, Kuchroo VK. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441: 235-238, 2006.
3. + regulatory T cells. Nat Rev Immunol 11: 119-130, 2011.
4. + regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 198: 1875-1886, 2003.
5. Colvin RB, Hirohashi T, Farris AB, Minnei F, Collins AB, Smith RN. Emerging role of B cells in chronic allograft dysfunction. Kidney Int Suppl 119: S13-S17, 2010.
6. Cueto-Manzano AM, Morales-Buenrostro LE, Gonzalez-Espinoza L, Gonzalez-Tableros N, Martin-del-Campo F, Correa-Rotter R, Valera I, Alberu J. Markers of inflammation before and after renal transplantation. Transplantation 80: 47-51, 2005.
7. Dienz O, Rincon M. The effects of IL-6 on CD4 T cell responses. Clin Immunol 130: 27-33, 2009.
8. Du C, Jiang J, Guan Q, Yin Z, Masterson M, Parbtani A, Zhong R, Jevnikar AM. Renal tubular epithelial cell self-injury through Fas/Fas ligand interaction promotes renal allograft injury. Am J Transplant 4: 1583-1594, 2004.
9. + precursors. Am J Transplant 4: 1614-1627, 2004.
10. Fujisaki J, Wu J, Carlson AL, Silberstein L, Putheti P, Larocca R, Gao W, Saito TI, Lo Celso C, Tsuyuzaki H, Sato T, Côté D, Sykes M, Strom TB, Scadden DT, Lin CP. In vivo imaging of Treg cells providing immune privilege to the haematopoietic stem-cell niche. Nature 474: 216-219, 2011.
11. Grimbert P, Mansour H, Desvaux D, Roudot-Thoraval F, Audard V, Dahan K, Berrehar F, Dehoulle-Poillet C, Farcet JP, Lang P, Le Gouvello S. The regulatory/cytotoxic graft-infiltrating T cells differentiate renal allograft borderline change from acute rejection. Transplantation 83: 341-346, 2007.
12. Kishimoto T. IL-6: from its discovery to clinical applications. Int Immunol 22: 347-352, 2010.
13. Kopf M, Herren S, Wiles MV, Pepys MB, Kosco-Vilbois MH. Interleukin 6 influences germinal center development and antibody production via a contribution of C3 complement component. J Exp Med 188: 1895-1906, 1998.
14. Laupacis A, Keown P, Pus N, Krueger H, Ferguson B, Wong C, Muirhead N. A study of the quality of life and cost-utility of renal transplantation. Kidney Int 50: 235-242, 1996.
15. Leenaerts PL, De Ruysscher D, Vandeputte M, Waer M. Measurement of alloantibody by flow cytometry. J Immunol Methods 130: 73-79, 1990.
16. Li XC, Turka LA. An update on regulatory T cells in transplant tolerance and rejection. Nat Rev Nephrol 6: 577-583, 2010.
17. Liang Y, Christopher K, Finn PW, Colson YL, Perkins DL. Graft produced interleukin-6 functions as a danger signal and promotes rejection after transplantation. Transplantation 84: 771-777, 2007.
18. Malan Borel I, Racca A, Garcia MI, Bailat A, Quiroga F, Soutullo A, Gaite L. Gammadelta T cells and interleukin-6 levels could provide information regarding the progression of human renal allograft. Scand J Immunol 58: 99-105, 2003.
19. Mangan PR, Harrington LE, O'Quinn DB, Helms WS, Bullard DC, Elson CO, Hatton RD, Wahl SM, Schoeb TR, Weaver CT. Transforming growth factor-beta induces development of the TH17 lineage. Nature 441: 231-234, 2006.
20. Marshall SE, McLaren AJ, McKinney EF, Bird TG, Haldar NA, Bunce M, Morris PJ, Welsh KI. Donor cytokine genotype influences the development of acute rejection after renal transplantation. Transplantation 71: 469-476, 2001.
21. McCullough KP, Keith DS, Meyer KH, Stock PG, Brayman KL, Leichtman AB. Kidney and pancreas transplantation in the United States, 1998-2007: access for patients with diabetes and end-stage renal disease. Am J Transplant 9: 894-906, 2009.
22. + cells. Am J Pathol 178: 1635-1645, 2011.
23. Muller-Steinhardt M, Ebel B, Hartel C. The impact of interleukin-6 promoter -597/-572/-174genotype on interleukin-6 production after lipopolysaccharide stimulation. Clin Exp Immunol 147: 339-345, 2007.
24. Nguan CY, Du C. Renal tubular epithelial cells as immunoregulatory cells in renal allograft rejection. Transplant Rev (Orlando) 23: 129-138, 2009.
25. Porcheray F, DeVito J, Yeap BY, Xue L, Dargon I, Paine R, Girouard TC, Saidman SL, Colvin RB, Wong W, Zorn E. Chronic humoral rejection of human kidney allografts associates with broad autoantibody responses. Transplantation 89: 1239-1246, 2010.
26. Raasveld MH, Weening JJ, Kerst JM, Surachno S, ten Berge RJ. Local production of interleukin-6 during acute rejection in human renal allografts. Nephrol Dial Transplant 8: 75-78, 1993.
27. Schnuelle P, Lorenz D, Trede M, Van Der Woude FJ. Impact of renal cadaveric transplantation on survival in end-stage renal failure: evidence for reduced mortality risk compared with hemodialysis during long-term follow-up. J Am Soc Nephrol 9: 2135-2141, 1998.
28. Suematsu S, Matsuda T, Aozasa K, Akira S, Nakano N, Ohno S, Miyazaki J, Yamamura K, Hirano T, Kishimoto T. IgG1 plasmacytosis in interleukin 6 transgenic mice. Proc Natl Acad Sci USA 86: 7547-7551, 1989.
29. Trivedi HL. Immunobiology of rejection and adaptation. Transplant Proc 39: 647-652, 2007.
30. + T cell-mediated graft rejection: implications for anti-CD154 immunotherapy. J Immunol 169: 5401-5404, 2002.
31. Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24: 179-189, 2006.
32. + cells in renal allografts during acute rejection. Am J Transplant 7: 914-922, 2007.
33. Waiser J, Budde K, Katalinic A, Kuerzdorfer M, Riess R, Neumayer HH. Interleukin-6 expression after renal transplantation. Nephrol Dial Transplant 12: 753-759, 1997.
34. Wang C, Cordoba S, Hu M, Bertolino P, Bowen DG, Sharland AF, Allen RD, Alexander SI, McCaughan GW, Bishop GA. Spontaneous acceptance of mouse kidney allografts is associated with increased Foxp3 expression and differences in the B and T cell compartments. Transpl Immunol 24: 149-156, 2011.
35. Wang S, Jiang J, Guan Q, Lan Z, Wang H, Nguan CY, Jevnikar AM, Du C. Reduction of Foxp3-expressing regulatory T cell infiltrates during the progression of renal allograft rejection in a mouse model. Transpl Immunol 19: 93-102, 2008.
36. + regulatory T cells in the induction and maintenance of transplantation tolerance. Transpl Immunol 17: 120-129, 2007.